Why the study?
Does reducing blood pressure variability prevent end-organ damage in animal models of hypertension?
Population
Animal models of hypertension (including sinoaortic-denervated and spontaneously hypertensive rats)
Design
Review
Authors
Loading...
Hypothesis-generating for targeting BP variability in hypertension; prospective human trials needed before clinical adoption.
Does reducing blood pressure variability prevent end-organ damage in animal models of hypertension?
Animal models suggest that blood pressure variability is an independent risk factor for end-organ damage, highlighting a potential new therapeutic target in hypertension.
Ding‐Feng Su (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: